Gemtuzumab

MedChem Express

Gemtuzumab

10

Research Use Only

Monoclonal

99.54

Gemtuzumab is a monoclonal IgG4-kappa antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC) , Gemtuzumab ozogamicin (HY-109539). Gemtuzumab ozogamicin consists of a cytotoxic derivative of Calicheamicin (a cytotoxic antibiotic), and a monoclonal antibody. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia [1] [2] .

-80°C

12352203